Drugs / Adelmidrol
Adelmidrol
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT01420510 | Sep 2011 → Nov 2014 | vaginitis | University of Insubria | Unknown | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT07675512 | Jan → Aug 2025 | chronic rhinosinusitis | University of Campania Luigi Vanvitelli | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Adelmidrol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07675512 ↗ |
| Known as | NSC-27132 | ChEMBL registry synonym — accepted as the source's own label CHEMBL2105967 ↗ |
| Known as | Rinidrol | “Adelmidrol nasal spray (Rinidrol) 2 puff for narix two times a day (morning and evening)” NCT07675512 ↗ |
| Modality | Small molecule | — CHEMBL2105967 ↗ |
| Route | Other | “Application of a Adelmidrol vaginal gel” NCT01420510 ↗ |